Identification and rapid global spread of the novel SARS-CoV-2 coronavirus with first cases of the disease COVID-19 being detected in Europe in January 2020 [1] necessitated the development and deployment of diagnostic tests for the specific detection of SARS-CoV-2 genome sequences in human samples.